Data / Form D filings / Ethicann Pharmaceuticals Inc. / DE
Ethicann Pharmaceuticals Inc. / DE: Form D filing
Ethicann Pharmaceuticals Inc. / DE, a pharmaceuticals company in Bethesda, MD, filed a Form D with the SEC in 2023. The latest, on March 6, 2023, reports an offering of no set size with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7710 WOODMONT AVE, SUITE 910, Bethesda, MD, 20814
- Phone
- (301) 529-6984
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1967784
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MICHAEL MYERS | Director | |
| DOUGLAS KAWAHARA | Executive Officer, Director | |
| NEIL MARUOKA | Director | |
| DWAYNE LASHYN | Director | |
| BRUCE MACKLER | Executive Officer, Director, Promoter | |
| BRANDON PRICE | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Maryland that filed recently
- Cerium Pharmaceuticals, Inc. $750,000 · Aug 6, 2026
Every Form D from the week of Mar 6, 2023 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ethicann Pharmaceuticals Inc. / DE reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.